CDC: Deadly Fungal Infections Spreading at an 'Alarming Rate'
The Centers for Disease Control and Prevention (CDC) on Monday warned that a deadly fungus called Candida auris (C. auris) is spreading at an "alarming rate" in the U.S. healthcare facilities.
“The rapid rise and geographic spread of cases is concerning and emphasizes the need for continued surveillance, expanded lab capacity, quicker diagnostic tests, and adherence to proven infection prevention and control,” said CDC epidemiologist Dr. Meghan Lyman, lead author of the paper, in a press release.
Adding to the agency's concerns, the number of infections that were resistant to echinocandins, which is the antifungal medicine most commonly used to treat C. auris infections, tripled in 2021.
The CDC classified C. auris as an "urgent antimicrobial resistance (AR) threat," meaning "it is often resistant to multiple antifungal drugs, spreads easily in healthcare facilities, and can cause severe infections with high death rates."
Between 2016, when C. auris was first reported, and 2021, there have been a total of 3,270 clinical cases reported and 7,413 screening cases.
The agency said "poor general infection prevention and control (IPC) practices in healthcare facilities" are responsible for the spread. However, expanded efforts to detect cases is also responsible for the jump in reported cases.
Cheddar's J.D. Durkin caught up with the head of NASA Bill Nelson, a former senator, who feels one thing that seems less rancorous on Capitol Hill these days is the work of the space agency.
Catching you up on what you need to know on April 22, 2022, with updates on a new Ukraine aid package, a new missile test by Russia, DOJ announcement of $150 Million in COVID-related fraud, the Florida senate supports Gov. DeSantis in stripping Disney of its special tax district, and more.
Scientists say a U.K. patient with a severely weakened immune system had COVID-19 for almost a year and a half. The case underscores the importance of protecting vulnerable people from the coronavirus.
Cheddar's Lawrence Banton speaks with entrepreneurs leading the way on textile and clothing recycling in an effort to help stem waste in fashion amid the climate crisis.
The FDA just approved a first-of-its-kind treatment for individuals with blood cancer that has proven results of 5-year survival rates. Christi Shaw, CEO of Kite, a Gilead company, joins Cheddar Innovates to discuss how this treatment works and compares to others currently on the market.
Dr. Neta Lavon, CTO and VP of R&D at Aleph Farms, joins Cheddar Innovates to discuss how the team sent cow cells to space to further research the production of meat in space, and why developing cultivated meat is so critical to the future of space travel.
Catching you up on what you need to know on April 21, 2022, with President Biden set to announce more security assistance funding to Ukraine, polls showing a majority of Americans in favor of transit mask mandates, rapper A$AP Rocky's arrest, and more.
Epidemiologist Dr. Eric Feigl-Ding joined Closing Bell to explain why ending the travel mask mandates could put the U.S. in a bad position in the coming months as new COVID-19 variants threaten to cause another spike in cases.
Laurence Tribe, a professor of constitutional law at Harvard University, joined Cheddar News to talk about the legal underpinnings of the ruling to lift the federal travel mask mandate. "Judge Mizelle decided that she would issue a nationwide injunction, which she and other conservatives have criticized in the past," he said. "That didn't stop her from doing it this time. She did it by just wiping away the CDC's rule, and she did it, have to say, in an opinion that was, well, I'll be honest, really stupid."
